Novartis Finishes Up $51.6B Alcon Purchase
By Ian Thoms · December 15, 2010, 1:49 PM EST
Swiss drug giant Novartis AG wrested full control of eye care company Alcon Inc. on Wednesday after almost a year of regulatory and shareholder battles in the $51.6 billion deal....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login